VYNE Therapeutics Inc.
USD0.66
+0.01 (+1.93%)
CEO
David T. Domzalski
IPO Date
2018-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.65
Prev. Close
$0.65
Day Low
$0.65
Day High
$0.66
52W Low
$0.28
52W High
$1.96
Market Cap
$0.01B
Volume
0.05M
| -3.6 |
| 31 Dec 2023 | FY | 100.0% | -6710.4% | -32.1% | -29.1% | 0.00 | 12.73 | -0.8 |
| 31 Dec 2022 | FY | 100.0% | -4865.8% | -74.4% | -56.9% | 0.00 | 4.10 | -0.4 |
| 31 Dec 2021 | FY | 100.0% | -7876.4% | -150.8% | -109.4% | 0.01 | 3.43 | -0.7 |
| 31 Dec 2020 | FY | 93.4% | -1217.4% | -681.6% | -272.6% | 0.93 | 4.01 | -0.8 |
| 31 Dec 2019 | FY | 21.0% | -15906.1% | -102.9% | -89.0% | 0.01 | 7.35 | -2.2 |
| 31 Dec 2018 | FY | 100.0% | -483.5% | -39.5% | -36.8% | 0.00 | 14.62 | -1.7 |
| 31 Dec 2017 | FY | 100.0% | -634.6% | 51.0% | -43.5% | 0.00 | 8.17 | -20.3 |
| 31 Dec 2016 | FY | 100.0% | -2087.2% | 47.8% | -33.5% | 0.00 | 8.08 | -44.5 |
| -1.3 |
| 30 Sept 2025 | Q3 | 100.0% | -4307.7% | -22.7% | -20.1% | 0.00 | 8.87 | -0.5 |
| 30 Jun 2025 | Q2 | 100.0% | -8340.6% | -14.8% | -12.9% | 0.00 | 7.60 | -3.1 |
| 31 Mar 2025 | Q1 | 100.0% | -4262.9% | -19.5% | -15.3% | 0.00 | 4.47 | -2.0 |
| 31 Dec 2024 | Q4 | 100.0% | -14311.9% | -23.1% | -18.0% | 0.00 | 4.35 | -3.0 |
| 30 Sept 2024 | Q3 | 100.0% | -10047.1% | -19.1% | -16.0% | 0.00 | 5.81 | -1.6 |
| 30 Jun 2024 | Q2 | 100.0% | -4750.5% | -12.6% | -10.9% | 0.00 | 7.13 | -2.2 |
| 31 Mar 2024 | Q1 | 100.0% | -6376.5% | -7.5% | -6.8% | 0.00 | 13.02 | -5.2 |
| 31 Dec 2023 | Q4 | 100.0% | -8142.1% | -7.0% | -6.3% | 0.00 | 12.73 | -2.9 |